Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort
- Conditions
- Chronic Venous Insufficiency
- Interventions
- Device: Dual Action Pneumatic Compression DeviceDevice: Standard Compression Garments
- Registration Number
- NCT02015221
- Lead Sponsor
- Tactile Medical
- Brief Summary
The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual action pneumatic compression device in patients with unilateral or bilateral chronic venous insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.
- Detailed Description
Subjects will be randomized to receive either the ACTitouch system or standard compression garments, and will respond to symptom surveys and quality of life surveys to assess comfort and ease of use of each. These will be conducted at Baseline, at Day 15 and Day 30.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 81
- Diagnosis of unilateral or bilateral CVI with or without leg ulcers
- Documented history of low adherence to compression garment therapy
- CEAP classification C3-C6
- Leg circumferences within the following ranges: Ankle 12-44cm, calf 22-6m, below the knee 22-68cm
- History of skin sensitivity to any of the components of ACTitouch or compression garments
- History of acute (deep vein thrombosis) DVT or (pulmonary embolism) PE within the last 3 months
- Ankle Brachial Index (ABI) < 0.8
- Acute thrombophlebitis
- History of pulmonary edema or decompensated congestive heart failure
- Currently has an active infection of the skin such as cellulitis requiring antibiotics
- Poorly controlled diabetes with an HbA1c value of >10%
- Exhibits any condition which, according to the PI, justifies the subjects exclusion from the study, such as a medical condition where an increase in venous or lymphatic return is undesirable.
- Subjects with open ulcers must be able to follow their care regimen for ulcer healing concurrently with the assigned study regimen.
- Participating in another clinical trial
- Changes to medications that affect edema within the last 30 days
- Currently pregnant or trying to become pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ACTitouch Dual Action Pneumatic Compression Device ACTitouch in sustained gradient compression mode during all waking hours (at least 10 hours per day) and intermittent pneumatic compression mode for 2 hours each day. Standard Compression Garments Standard Compression Garments Standard Compression Garments of compression levels 30mmHg to 40mmHg during all waking hours each day.
- Primary Outcome Measures
Name Time Method Ease of Use and Comfort for Subjects Using the ACTitouch System. 30 days Ease of application and removal (donning and doffing) the treatment at the baseline visit. Comfort of treatment after the treatment was first applied.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (11)
Empire Orthopedic Center
๐บ๐ธColton, California, United States
Long Beach VA Healthcare System
๐บ๐ธLong Beach, California, United States
Jobst Vascular Institute
๐บ๐ธToledo, Ohio, United States
Associated Foot and Ankle Specialists, LLC
๐บ๐ธPhoenix, Arizona, United States
Stony Brook Vein Center
๐บ๐ธStony Brook, New York, United States
University Hospitals Case Medical Center
๐บ๐ธCleveland, Ohio, United States
Ohio Health System
๐บ๐ธColumbus, Ohio, United States
VA Loma Linda Healthcare System
๐บ๐ธLoma Linda, California, United States
Greenville Hospital System
๐บ๐ธGreenville, South Carolina, United States
Park Nicollet Heart and Vascular Center
๐บ๐ธMinneapolis, Minnesota, United States
University of California, San Diego
๐บ๐ธLa Jolla, California, United States